Effects of CX516 on Functioning in Fragile X Syndrome and Autism

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00054730
Recruitment Status : Completed
First Posted : February 11, 2003
Last Update Posted : June 24, 2005
FRAXA Research Foundation
Information provided by:

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : No date given

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 January 27, 2016
February 23, 2016
2 March 29, 2016
May 2, 2016
3 October 3, 2016
November 22, 2016
4 October 9, 2017
July 20, 2018